- Chart
- Upturn Summary
- Highlights
- Valuation
- About
Gabelli Healthcare & WellnessRx Trust(GRX)
Advisory History & Simulated Performance *
*as per simulation (see disclosures)- ALL
- 1Y
- 1M
- 1W
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- PASS (Skip)
Advisory Performance History (Simulated)
Upturn Advisory & Investor View for GRX
09/14/2026: GRX (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Gabelli Healthcare & WellnessRx Trust (GRX) is a closed-end fund providing exposure to the global healthcare and wellness sectors. The fund is designed for investors seeking regular monthly income alongside potential capital appreciation, leveraging the research-intensive management style of Gabelli Funds. Its primary strength lies in its specialized, active approach to identifying value in biotech, pharma, and health-related wellness. However, investors face risks including share price volatility, potential discounts to net asset value, and sector-specific regulatory headwinds. The fund is best suited for income-focused investors who understand the risks of active sector-specific funds and wish to monitor distributions and the fund's trading premium or discount regularly.
How to Read the Upturn Advisory
The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.
Company fundamentals, valuation, risks, and news provide supporting context about the business.
Investor Fit
| Investor style | Fit | Why |
|---|---|---|
| Growth investor | Mixed fit | While it focuses on growth sectors like biotech, the fund's income mandate may limit pure capital appreciation potential. |
| Momentum investor | Weak fit | The fund is generally managed for long-term thematic exposure rather than capturing short-term market momentum. |
| Value investor | Strong fit | The Gabelli approach is fundamentally rooted in identifying undervalued assets, which aligns well with value investing principles. |
| Dividend investor | Strong fit | The fund is specifically structured to provide regular monthly distributions to investors. |
| Low-risk investor | Weak fit | As an equity-focused closed-end fund with sector concentration, it carries significant market and volatility risk. |
Risk Profile
| Risk factor | Level | Why it matters |
|---|---|---|
| Price volatility | Medium / high | As an equity CEF, the fund's market price can fluctuate significantly based on market sentiment. |
| Valuation risk | Medium | The share price may trade at a premium or discount to the underlying Net Asset Value. |
| Competition risk (healthcare sector concentration) | Medium | Concentration in a single sector makes the fund vulnerable to regulatory and political changes in healthcare. |
| Business quality | Strong | The fund employs a disciplined, research-intensive investment process backed by a veteran management team. |
| Dividend income | Medium | Distributions are not guaranteed and can fluctuate based on the income generated by the portfolio. |
| Execution risk | Medium | The manager's ability to pick successful stocks within the complex healthcare sector is key to performance. |
Price Behavior

Steady Uptrend
The stock demonstrates consistent and steady upward price momentum.

Very Smooth
The stock has followed a highly orderly price path with minimal short-term disruption.
Analysis of Past Performance
Type Stock | Historic Profit 18.04% | Avg. Invested days 56 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Advisory Rating ![]() | Upturn Advisory Performance | Stock Returns Performance |
Upturn Scorecard
Upturn Star Rating 
Company Fundamentals 
Financial Health Rating 
Growth Momentum Score 
Ownership 
Unit Economics (Per $1K Revenue) 
Economic Dimensions
Quantitative Style Profile 
Style Classification
Quality Focused
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 141.37M USD | Price to earnings Ratio 17.05 | 1Y Target Price - |
Price to earnings Ratio 17.05 | 1Y Target Price - | ||
Volume (30-day avg) 22.8K shares | Beta - | 52 Weeks Range 8.47 - 10.20 | Updated Date 09/14/2026 |
52 Weeks Range 8.47 - 10.20 | Updated Date 09/14/2026 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.57 |
How Company Makes Money
| Business area | What it includes | Retail investor read |
|---|---|---|
| Investment Portfolio | Holdings in pharmaceutical, biotech, and wellness companies. | You earn money from dividends and potential share price growth generated by the underlying healthcare stocks. |
Valuation
Trailing PE 17.05 | Forward PE - | Enterprise Value - | Price to Sales(TTM) 16.92 |
Enterprise Value - | Price to Sales(TTM) 16.92 | ||
Enterprise Value to Revenue 15.96 | Enterprise Value to EBITDA - | Shares Outstanding 14.54M | Shares Floating - |
Shares Outstanding 14.54M | Shares Floating - | ||
Percent Insiders 1.77 | Percent Institutions 41.02 |
Upturn AI Summary
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
Financial Metrics
🧭 Investment Snapshot
Total Revenue (Scale)
Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.
Net Income (Profit)
Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.
Free Cash Flow (Cash Strength)
Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.
📈 Growth & Strength
Operating Income (Core Profit)
Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.
EBITDA (Cash Earnings)
Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.
Gross Profit (Unit Profitability)
Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.
🛡️ Financial Safety
Cash (Liquidity Buffer)
Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.
Total Debt (Leverage Risk)
Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.
Net Working Capital (Short-Term Health)
Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.
🧱 Balance Sheet Strength
Stockholder Equity (Net Worth)
Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.
Total Assets (Asset Base)
The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.
Income Before Tax (Pre-Tax Earnings)
Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.
⚙️ Cost & Drag Factors
Cost of Revenue (Production Cost)
Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.
Total Operating Expenses (Operating Cost)
Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.
Income Tax Expense (Tax Drag)
Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.
About Gabelli Healthcare & WellnessRx Trust
Exchange NYSE | Headquarters Rye, NY, United States | ||
IPO Launch date 2007-06-19 | CEO - | ||
Sector Financial Services | Industry Asset Management | Full time employees - | |
Full time employees - | |||
The Gabelli Healthcare & Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.

Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.
All company names, trademarks, logos, and brands are the property of their respective owners and are used for identification and informational purposes only. Use of these names, trademarks, and logos does not imply endorsement by their respective owners.

